IL17B and breast carcinoma: Mechanistic studies in the MDA-MB 361, MDA-MB468, and MCF-7 breast cancer cell lines revealed that IL-17B promotes breast cancer cells survival in vitro by activating the ERK and NF-kB pathways and by enhancing the expression of anti-apoptotic Bcl-2 family members (10, 28).